Immunic Inc’s filing revealed that its Executive Chairman Nash Duane acquired Company’s shares for reported $16694.0 on Jun 13 ’25. In the deal valued at $0.83 per share,20,000 shares were bought. As a result of this transaction, Nash Duane now holds 36,032 shares worth roughly $29906.559999999998.
Then, Tardio Jason bought 12,512 shares, generating $9,884 in total proceeds. Upon buying the shares at $0.79, the President and COO now owns 12,512 shares.
Before that, Vitt Daniel bought 15,000 shares. Immunic Inc shares valued at $11,550 were divested by the CEO and Director at a price of $0.77 per share. As a result of the transaction, Vitt Daniel now holds 29,000 shares, worth roughly $24070.0.
Chardan Capital Markets initiated its Immunic Inc [IMUX] rating to a Buy in a research note published on September 29, 2025; the price target was $13. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in late March with a ‘”an Outperform”‘ rating. H.C. Wainwright began covering IMUX with “Buy” recommendation on November 25, 2024.
Price Performance Review of IMUX
On Monday, Immunic Inc [NASDAQ:IMUX] saw its stock jump 8.79% to $0.83. Over the last five days, the stock has lost -0.17%. Immunic Inc shares have fallen nearly -41.61% since the year began. Nevertheless, the stocks have fallen -16.50% over the past one year. While a 52-week high of $1.45 was reached on 02/21/25, a 52-week low of $0.56 was recorded on 05/29/25.
Levels Of Support And Resistance For IMUX Stock
The 24-hour chart illustrates a support level at 0.7901, which if violated will result in even more drops to 0.7452. On the upside, there is a resistance level at 0.8649. A further resistance level may holdings at 0.8948.
How much short interest is there in Immunic Inc?
A steep rise in short interest was recorded in Immunic Inc stocks on 2025-10-15, dropping by -0.52 million shares to a total of 9.49 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 10.01 million shares. There was a decline of -5.47%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 27, 2024 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $6 price target.
